New hope for leukemia patients after other treatments fail
NCT ID NCT06684964
Summary
This study is observing how well a medication called asciminib works for adults in Saudi Arabia with a type of chronic leukemia. It is for patients who have already tried at least two other standard treatments. Researchers will follow about 40 patients for a year to see how effective the drug is, how well patients tolerate it, and if they stick with taking it as prescribed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGDammam, 15215, Saudi Arabia
-
Novartis Investigative Site
RECRUITINGJeddah, 21423, Saudi Arabia
-
Novartis Investigative Site
RECRUITINGRiyadh, 11211, Saudi Arabia
-
Novartis Investigative Site
RECRUITINGRiyadh, 11426, Saudi Arabia
Conditions
Explore the condition pages connected to this study.